1186.5000 -4.80 (-0.40%)
NSE Jan 14, 2026 15:31 PM
Volume: 2.8M
High volume today

logo
Dr. Reddy's Laboratories Ltd.
13 Apr 2021, 12:00AM
1186.50
-0.40%
Axis Direct
The Sputnik-V vaccine has been given Emergency Use Authorization by the Indian govt. The vaccine has a proven efficacy rate of 91.5 percent, which is the highest after the candidates of Moderna Inc and Pfizer-BioNTech. The cost of Sputnik V could be in the range of $3.5 per dose.
Number of FII/FPI investors decreased from 917 to 872 in Sep 2025 qtr
More from Dr. Reddy's Laboratories Ltd.
Recommended